Carlyle Builds Diverse Generic Platform With India’s Viyash Life Sciences
Global Private Equity Fund First Invested In Firm In June 2021
Viyash Life Sciences said it intended to seek further investment opportunities to build scale after establishing an integrated generic pharmaceutical platform in India in partnership with the private equity giant Carlyle.
